Literature DB >> 17932367

Prediagnostic C-peptide and risk of prostate cancer.

Marilyn J Borugian1, John J Spinelli, Zheng Sun, Laurence N Kolonel, Ingrid Oakley-Girvan, Michael D Pollak, Alice S Whittemore, Anna H Wu, Richard P Gallagher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17932367     DOI： 10.1158/1055-9965.EPI-07-0495

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  6 in total

1.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Marian L Neuhouser; Cathee Till; Alan Kristal; Phyllis Goodman; Ashraful Hoque; Elizabeth A Platz; Ann W Hsing; Demetrius Albanes; Howard L Parnes; Michael Pollak
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

2.  Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.

Authors:  Yin Cao; Katharina Nimptsch; Irene M Shui; Elizabeth A Platz; Kana Wu; Michael N Pollak; Stacey A Kenfield; Meir J Stampfer; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2014-11-10       Impact factor: 7.396

3.  Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.

Authors:  Gabriel Y Lai; Kathy J Helzlsouer; Sandra L Clipp; Nader Rifai; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2010-09-21

4.  Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.

Authors:  Gabriel Y Lai; Edward L Giovannucci; Michael N Pollak; Sarah B Peskoe; Meir J Stampfer; Walter C Willett; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2014-03-25       Impact factor: 2.506

5.  Serum C-peptide concentration and prostate cancer: A meta-analysis of observational studies.

Authors:  Zhen-Lang Guo; Xiang-Tao Weng; Franky-Leung Chan; Lei-Liang Gong; Song-Tao Xiang; Shu Gan; Chi-Ming Gu; Shu-Sheng Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

Review 6.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.